Cytokine-induced arginase activity in pulmonary endothelial cells is dependent on Src family tyrosine kinase activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 295, Issue 4, 2008, Pages

  Chang, Rossana ^d   Chicoine, Louis G ^a,b   Cui, Hongmei ^a,b   Kanagy, Nancy L ^d   Walker, Benjimen R ^d   Liu, Yusen ^a,b   English, B Keith ^c   Nelin, Leif D ^a,b,e  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e Center for Perinatal Research   (United States)

Author keywords

Inducible nitric oxide synthase; L arginine; Lipopolysaccharide; Lung injury

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ARGINASE; ARGINASE 2; BLK PROTEIN; CYTOKINE; HERBIMYCIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA; DEXAMETHASONE; PRIMER DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; LUNG INJURY; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PULMONARY ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CATTLE; DRUG EFFECT; GENETICS; LUNG CIRCULATION; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ARGINASE; CATTLE; CYTOKINES; DEXAMETHASONE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY CIRCULATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; UREA;

EID: 56149113636     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00504.2007     Document Type: Article

References (45)

1. Achen MG, Clauss M, Schnürch H, Risau W. The non-receptor tyrosine kinase lyn is localized in the developing murine blood-brain barrier. Differentiation 59: 15-24, 1995.
2. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 25: 639-653, 2004.
3. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE. TNF-α increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 291: L1232-L1245, 2006.
4. Bachetti T, Comini L, Curello S, Bastianon D, Palmieri M, Bresciani G, Callea F, Ferrari R. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. J Mol Cell Cardiol 37: 939-945, 2004.
5. Bull HA, Brickell PM, Dowd PM. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett 351: 41-44, 1994.
6. Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC, Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol 175: 3846-3861, 2005.
7. Chang IC, Zoghi B, Liao JC, Kuo L. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J Immunol 165: 2134-2141, 2000.
8. Chen W, Jump DB, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaneoic acid. Invest Ophthalmol Vis Sci 48: 18-26, 2007.
9. Chicoine LG, Paffett ML, Young TL, Nelin LD. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 287: L60-L68, 2004.
10. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924, 1999.
11. Gebb S, Stevens T. On lung endothelial cell heterogeneity. Microvasc Res 68: 1-12, 2004.
12. Geiger M, Stone A, Mason SN, Oldham KT, Guice KS. Differential nitric oxide production by microvascular and macrovascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 273: L275-L281, 1997.
13. Godambe SA, Knapp KM, Meals EA, English BK. Role of vav1 in the lipopolysaccharide-mediated upregulation of inducible nitric oxide synthase production and nuclear factor for interleukin-6 expression activity in murine macrophages. Clin Diagn Lab Immunol 11: 525-531, 2004.
14. Hoet PHM, Nemery B. Polyamines in the lung: polyamine uptake and polyamine-linked pathological and toxicological conditions. Am J Physiol Lung Cell Mol Physiol 278: L417-L433, 2000.
15. Johnson BA, Pitt BR, Davies P. Pulmonary arterial smooth muscle modulate cytokine- and LPS-induced cytotoxicity in endothelial cells. Am J Physiol Lung Cell Mol Physiol 278: L460-L468, 2000.
16. Kanda S, Mochizuki Y, Nakamura T, Miyata Y, Matsuyama T, Kanetake H. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2- induced capillary morphogenesis of endothelial cells through fyn. J Cell Sci 118: 961-970, 2005.
17. 2+ and permeability. Am J Physiol Lung Cell Mol Physiol 274: L810-L819, 1998.
18. Kim YM, Kim YM, Lee YM, Kim HS, Kim JD, Choi Y, Kim KW, Lee SY, Kwon YG. TNF-related activation-induced cytokine induces angiogenesis through the activation of Src and phospholipase C in human endothelial cells. J Biol Chem 277: 6799-6805, 2002.
19. King J, Hamil T, Creighton J, Wu S, Bhat P, McDonald F, Stevens T. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 67: 139-151, 2004.
20. Kinney CM, Chandrasekharan UM, Mavrakis L, DiCorleto PE. VEGF and thrombin induce MAP kinase phosphatase-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration. Am J Physiol Cell Physiol 294: C241-C250, 2008.
21. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384: 1343-1364, 2003.
22. Knapp KM, English BK. Ceramide-mediated stimulation of inducible nitric oxide synthase (iNOS) and tumor necrosis factor (TNF) accumulation in murine macrophages requires tyrosine kinase activity. J Leukoc Biol 67: 735-741, 2000.
23. Kox M, Wijetunge S, Pickkers P, Hughes AD. Inhibition of src family tyrosine kinases prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteries. Vasc Pharmacol 46: 195-200, 2007.
24. Kolyada AY, Madias NE. Transcriptional regulation of the human iNOS gene by IL-1β in endothelial cells. Mol Med 7: 329-343, 2001.
25. Kuldo JM, Ogawara KI, Werner N, Asgeirsdottir SA, Kamps JA, Kok RJ, Molema G. Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 3: 11-39, 2005.
26. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, Gingras D, Béliveau R. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 279: 52132-52140, 2004.
27. Li H, Meininger CJ, Hawker JR, Haynes TE, Kepka-Lenhart D, Mistry SK, Morris SM, Wu G. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 280: E75-E82, 2001.
28. Li X, Lerea KM, Li J, Olson SC. Src kinase mediates angiotensin II-dependent increase in pulmonary endothelial nitric oxide synthase. Am J Respir Cell Mol Biol 31: 365-372, 2004.
29. Lowell CA. Src-family tyrosine kinases: rheostats of immune cell signaling. Mol Immunol 41: 631-643, 2004.
30. Maejima Y, Ueba H, Kuroki M, Yasu T, Hashimoto S, Nabata A, Kobayashi N, Ikeda N, Saito M, Kawakami M. Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth. Atherosclerosis 167: 89-95, 2003.
31. Nelin LD, Wang X, Zhao Q, Chicoine LG, Young TL, Hatch DM, English BK, Liu Y. MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge. Am J Physiol Cell Physiol 293: C632-C640, 2007.
32. Nelin LD, Nash HE, Chicoine LG. Cytokine treatment increases arginine metabolism and uptake in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 281: L1232-L1239, 2001.
33. Okutani D, Lodyga M, Han B, Liu M. Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol 291: L129-L141, 2006.
34. Orlicek SL, Hanke JH, English BK. The src family-selective tyrosine kinase inhibitor PP1 blocks LPS and IFN-γ-mediated TNF and iNOS production in murine macrophages. Shock 12: 350-354, 1999.
35. Purdie KJ, Whitley GSJ, Johnstone AP, Cartwright JE. Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc Res 54: 659-668, 2002.
36. Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YC. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol Lung Cell Mol Physiol 275: L96-L102, 1998.
37. Shearer JD, Richards JR, Mills CD, Caldwell MD. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol Endocrinol Metab 272: E181-E190, 1997.
38. Stanley KP, Chicoine LG, Young TL, Reber KM, Lyons CR, Liu Y, Nelin LD. Gene transfer with inducible nitric oxide synthase decreases production of urea by arginase in pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 290: L298-L306, 2006.
39. Stevens T, Creighton J, Thompson WJ. Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function. Am J Physiol Lung Cell Mol Physiol 277: L119-L126, 1999.
40. Stovall SH, Yi AK, Meals EA, Talati AJ, Godambe SA, English BK. Role of vav1- and src-related tyrosine kinases in macrophage activation by CpG DNA. J Biol Chem 279: 13809-13816, 2004.
41. Szczepankiewicz A, Breborowicz A, Skibinska M, Wilkosc M, Tomaszewska M, Hauser J. Association analysis of tyrosine kinase fyn gene polymorphisms in asthmatic children. Int Arch Allergy Immunol 145: 43-47, 2007.
42. Tiruppathi C, Naqvi T, Sandoval R, Mehta D, Malik AB. Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol 281: L958-L968, 2001.
43. Wang Q, Pfeiffer GR, Gaarde WA. Activation of src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells. J Biol Chem 278: 47731-47743, 2003.
44. Werdich XQ, Penn JS. Src, fyn and yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis 8: 315-326, 2005.
45. Witte MB, Barbul A. Arginine physiology and its implications for wound healing. Wound Repair Regen 11: 419-423, 2003.